Related Experiment Video

Updated: Jul 29, 2025

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

12.1K

Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site

Zander Schwartz1,2, Piao Zhao2,3, Annie Wang2

  • 1School of Biomedical Engineering, Vanderbilt University, Nashville, TN 37235, USA.

Genes & Diseases
|May 24, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
11:37

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

6.7K
High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

10.9K

Related Experiment Videos

Last Updated: Jul 29, 2025

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

12.1K
Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
11:37

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

6.7K
High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

10.9K

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K

Articles linked to this work by shared authors, journal, and citation graph.

Trans-articular Bridge Plating for Gunshot-related Periarticular Hand Fractures.

Techniques in hand & upper extremity surgery·2026

RETRACTED: Gorska-Ponikowska et al. The Major Heat Shock Proteins, Hsp70 and Hsp90, in 2-Methoxyestradiol-Mediated Osteosarcoma Cell Death Model. Int. J. Mol. Sci. 2020, 21, 616.

International journal of molecular sciences·2026

Hospital frailty risk score and 90-day mortality in patients receiving venoarterial extracorporeal membrane oxygenation.

Perfusion·2026

Extended Support With an Impella 5.5: Single-Center Experience and Outcomes.

Artificial organs·2026

Late-Onset Development of Compartment Syndrome Following Penetrating Extremity Trauma With Vascular Injury: A Case Report.

Case reports in orthopedics·2026

Distal Femoral Interlocking Screw Length Can be Estimated Using "Anatomic Zones" During Femoral Intramedullary Nailing.

Orthopaedic surgery·2026

Gut microbial histamine and serotonin promote cerebrovascular angiogenesis: Evidence from moyamoya disease.

Genes & diseases·2026

Betaine alleviates renal osteodystrophy by stabilizing ABCG1 mRNA to inhibit HMOX1-mediated ferroptosis in BMSCs.

Genes & diseases·2026

Glis1 regulates metabolic programming by promoting H3K18 lactylation to alleviate neuronal senescence following spinal cord injury.

Genes & diseases·2026

Echinocystic acid inhibits the growth of human bladder cancer cells by suppressing AKT1/GSKβ/β-Catenin signaling and synergizes with gemcitabine.

Genes & diseases·2026

Targeting hepatic CREBZF protects against atherosclerosis via exosomal miR-210-3p mediated inhibition of endothelial inflammation.

Genes & diseases·2026

Identification and functional analysis of sRNAs in Pseudomonas aeruginosa quorum sensing and virulence regulation.

Genes & diseases·2026

Menin inhibition with revumenib clears measurable residual disease in acute myeloid leukemia with UBTF tandem duplication after allogeneic stem cell transplantation.

Haematologica·2026

Navigating the landscape of stem cell therapeutics: Overcoming translational hurdles via emerging technologies and regulatory frontiers.

Pharmacology & therapeutics·2026

Immunosuppressive termination of pro-inflammatory miRNA degradation via circular RNA nanosponge for sepsis-induced cardiomyopathy treatment.

Journal of controlled release : official journal of the Controlled Release Society·2026

Resiquimod Improves the Tumor Accumulation and Antitumor Activity of SN38 Prodrug-Loaded Liposomes.

Molecular pharmaceutics·2026

Stem Cell and EV/sEV Strategies for Neuroimmune Niche Reprogramming in Selected CNS Disorders: Mechanisms, Engineered Delivery, and Translational Readiness.

CNS neuroscience & therapeutics·2026

A comparison of overall survival and quality of life in patients with MDS treated with azacytidine vs decitabine.

Blood neoplasia·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us